Menu

Enliven Therapeutics, Inc. ELVN

Full chart Compare
Set alert

Price alert · ELVN

All alert types
49.43 USD +4.64 (+10.36%)

At closeNov 6, 2026, 7:58 PM EST

49.75 +0.32 +0.65%

After hours · Nov 6, 7:58 PM ET

44.55 Day range 49.66
15.14 52-week range 61.15
YTD
+220.97%
1 year
+170.11%

Ownership

Held by insiders 6.22%
Held by institutions 116.65%
Float held by institutions 124.39%
Institutions 307

Top institutional holders

Top institutional holders
Holder% heldSharesValueReported
FMR, LLC13.68%10,025,017495.54MJun 29, 2026
Orbimed Advisors LLC.9.25%6,776,632334.97MJun 29, 2026
Polar Capital Holdings PLC8.78%6,430,636317.87MJun 29, 2026
Blackrock Inc.5.95%4,359,704215.50MJun 29, 2026
Vestal Point Capital, LP5.46%4,000,000197.72MJun 29, 2026
Commodore Capital Lp4.47%3,275,000161.88MJun 29, 2026

Top mutual fund holders

Top mutual fund holders
Holder% heldSharesValueReported
VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund2.57%1,883,37293.10MJun 29, 2026
iShares Trust-iShares Russell 2000 ETF2.06%1,508,36474.56MSep 29, 2026
Fidelity Select Portfolios-Select Health Care Portfolio1.75%1,280,00063.27MSep 29, 2026
Fidelity Securities Fund-Fidelity Small Cap Growth Fund1.71%1,250,75461.82MAug 30, 2026
Fidelity Rutland Square TRT II-Strategic Advisers Fidelity U.S. Total 1.53%1,123,26355.52MSep 29, 2026
T. Rowe Price New Horizons Fund, Inc.1.10%807,32939.91MJun 29, 2026
ELVN insiders
InsiderRelationLatest transactionDateShares held
COLLINS HELEN LOUISEOfficerSaleOct 18, 202625,000
DERYNCK MIKA KDirectorSaleAug 3, 20260
GARLAND J SCOTTDirectorSaleSep 30, 20260
HEYMAN RICHARD ADirectorSaleFeb 16, 20260
HOHL BENJAMINChief Financial OfficerSaleOct 18, 202638,000
KINTZ SAMUELChief Executive OfficerSaleNov 16, 20250